Ameritas Investment Partners’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.2K | Buy |
+9,267
| New | +$13.2K | ﹤0.01% | 2858 |
|
2024
Q2 | – | Sell |
-6,900
| Closed | -$8.56K | – | 3123 |
|
2024
Q1 | $8.56K | Hold |
6,900
| – | – | ﹤0.01% | 2854 |
|
2023
Q4 | $7.25K | Hold |
6,900
| – | – | ﹤0.01% | 2919 |
|
2023
Q3 | $47.3K | Buy |
6,900
+1,731
| +33% | +$11.9K | ﹤0.01% | 2142 |
|
2023
Q2 | $53.6K | Hold |
5,169
| – | – | ﹤0.01% | 2006 |
|
2023
Q1 | $41.8K | Hold |
5,169
| – | – | ﹤0.01% | 2083 |
|
2022
Q4 | $85.8K | Buy |
5,169
+630
| +14% | +$10.5K | ﹤0.01% | 1709 |
|
2022
Q3 | $71K | Hold |
4,539
| – | – | ﹤0.01% | 1727 |
|
2022
Q2 | $63K | Buy |
4,539
+560
| +14% | +$7.77K | ﹤0.01% | 1834 |
|
2022
Q1 | $69K | Hold |
3,979
| – | – | ﹤0.01% | 1866 |
|
2021
Q4 | $58K | Hold |
3,979
| – | – | ﹤0.01% | 2035 |
|
2021
Q3 | $72K | Buy |
3,979
+575
| +17% | +$10.4K | ﹤0.01% | 1901 |
|
2021
Q2 | $60K | Buy |
+3,404
| New | +$60K | ﹤0.01% | 2065 |
|
2020
Q2 | – | Sell |
-2,238
| Closed | -$2K | – | 3060 |
|
2020
Q1 | $2K | Hold |
2,238
| – | – | ﹤0.01% | 2949 |
|
2019
Q4 | $4K | Hold |
2,238
| – | – | ﹤0.01% | 2914 |
|
2019
Q3 | $2K | Hold |
2,238
| – | – | ﹤0.01% | 3009 |
|
2019
Q2 | $5K | Hold |
2,238
| – | – | ﹤0.01% | 2936 |
|
2019
Q1 | $13K | Hold |
2,238
| – | – | ﹤0.01% | 2583 |
|
2018
Q4 | $17K | Hold |
2,238
| – | – | ﹤0.01% | 2422 |
|
2018
Q3 | $32K | Hold |
2,238
| – | – | ﹤0.01% | 2241 |
|
2018
Q2 | $45K | Buy |
2,238
+469
| +27% | +$9.43K | ﹤0.01% | 2046 |
|
2018
Q1 | $31K | Hold |
1,769
| – | – | ﹤0.01% | 2183 |
|
2017
Q4 | $44K | Hold |
1,769
| – | – | ﹤0.01% | 1990 |
|
2017
Q3 | $45K | Hold |
1,769
| – | – | ﹤0.01% | 1955 |
|
2017
Q2 | $48K | Buy |
1,769
+1,067
| +152% | +$29K | ﹤0.01% | 1928 |
|
2017
Q1 | $21K | Buy |
+702
| New | +$21K | ﹤0.01% | 2367 |
|